It certainly jumped out at me. While running a standard screen for value stocks, I came across Argan, Inc. (AGX). Trading at $18.75 (as of this writing), the company had $14.06 per share in cash, and no debt. Meanwhile, trailing earnings per share were $1.44, forward earnings $1.40 per share, and its price-to-free cash flow ratio just 4.21, meaning the company had generated roughly its entire enterprise value in free cash over the past 12 months.
As it turned out, I wasn't the only one who was fooled, at least momentarily. I immediately noticed something curious, though: Argan's book value per share was $8.10, well below its cash balance. With no debt, how could this be?...
Only subscribers can access this article, which is part of the PRO research library covering 3,574 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: